Upload
drsm03
View
186
Download
8
Embed Size (px)
Citation preview
1
Basic Pharmacology
Welcome to NUR 106Basic Pharmacology
For NursesFor Nurses
Instructor: M Kroning, RN MSN
Basic Pharmacology For NursesBasic Pharmacology For Nurses• Welcome to NUR 106
• Instructor: Maureen Kroning, RN MSN
• Office: Ext: 4707Office: Ext: 4707
• Office location: Academic II Rm: 2305
• Office hours: Wed 1-6pm
Slide 2Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc .
Basic Pharmacology For NursesBasic Pharmacology For Nurses
• Text book: Authors : Clayton, Stock and Harroun 14th Edition
• Chapters:
1,2,3,7,8,9,10,11,12,14,16,20,23,25,27,29,30,33,34,35, 36, 42,46,48
Slide 3Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc .
2
NUR 106: Course ScheduleNUR 106: Course Schedule• 1/24: Ch: 1,2• 1/31: Ch: 3,7,8• 2/7: Ch: 9, 10• 2/14: Exam 1• 2/21: Ch: 11,12, 142/21: Ch: 11,12, 14• 2/28: Ch: 16,20,23• 3/7: Ch: 25,29• 3/14: Exam 2
Slide 4Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc .
NUR 106: Course Schedule Cont’dNUR 106: Course Schedule Cont’d
• 3/21: Ch: 30,33• 3/28: Ch: 34,35• 4/4: No Classes• 4/11: 27,36 • 4/18: Exam 34/18: Exam 3 • 4/25: Ch: 42, 46• 5/2: Ch: 48• 5/9: Last Day of Class- Exam 4
Slide 5Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc .
Chapter 1Chapter 1Definitions, Names, Standards, and Informational Sources
Slide 6Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc .
Foundations of Pharmacology
3
Types of Drug Names:Types of Drug Names:
Chemical
Generic
Official
Slide 7Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc .
Trademark (brand)
Proprietary
CHEMICAL NAMECHEMICAL NAME
Slide 8Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc .
Sources of Drug InformationSources of Drug Information• American Drug Index• American Hospital Formulary Service• Drug Interaction Facts• Drug Facts and Comparisons• Handbook on Injectable Drugs
Slide 9Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc .
Handbook on Injectable Drugs• Handbook of Nonprescription Drugs• Martindale–The Complete Drug Reference• Package inserts• Natural Medicines Comprehensive Database• Physicians’ Desk Reference (PDR)• Nursing journals
4
Sources of Patient Sources of Patient InformationInformation
• United States Pharmacopeia Dispensing Information (USPDI)
Slide 10Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc .
• Therapeutic Choices
U.S. Drug LegislationU.S. Drug Legislation
• Federal Food, Drug, and Cosmetic Act (1938, 1952, 1962)
Slide 11Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc .
• Controlled Substances Act (1970)
Foundations of Pharmacology Foundations of Pharmacology
• Drug review process
Slide 12Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc .
5
Chapter 2Chapter 2Principles of Drug Action and Drug Interactions
Slide 1Mosby items and derived items © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Basic principlesBasic principles
A strong understanding of the human body’s processes are important to grasp drug actions and drug interactions in the body
Slide 14Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Examples:Examples:
Antagonist—beta blockers
Agonist—epinephrine
Slide 15Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Partial agonist—pentazocine
6
Drug Stages After AdministrationDrug Stages After Administration
• Absorption
• Distribution
Slide 16Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Metabolism
• Excretion
Categories of Drug Administration
• Enteral route: PO, Rectal, NG
• Parenteral route: subQ, IM, IV
• Percutaneous route: inhalation, sublingual,Percutaneous route: inhalation, sublingual, topical
HalfHalf--life of Drugslife of Drugs
• Factors modifying the quantity of drug reaching a site of action after a single oral dose
Slide 18Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
7
Terms used in relationship to Terms used in relationship to medicationsmedications
• Desired action
• Side effects/ Adverse effects
• Allergic reactions: i.e. hives, urticaria
• Idiosyncratic reactions
• Carcinogenicity
• TeratogenSlide 19
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Principles of Drug Action and Principles of Drug Action and Drug InteractionsDrug Interactions
• Desired effect: when a drug enters a patient, is absorbed and distributed, and produces the expected response
• Adverse effect: “Any noxious, unintended and d i d ff t f d hi h t
Slide 20Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
undesired effect of a drug, which occurs at doses used in humans for prophylaxis, diagnosis or therapy” (World Health Organization)
Principles of Drug Action and Principles of Drug Action and Drug Interactions (cont’d)Drug Interactions (cont’d)
• Drug interaction
Drug interactions represent 3% to 6% of preventable in-hospital adverse drug reaction cases
Slide 21Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
cases
Drug interactions are a major component of the number of hospital emergency department visits and admissions
8
Factors Influencing Drug Action
• Age• Body weight• Metabolic rate• Illness• Psycological aspectsPsycological aspects• Tolerance• Drug dependence• Cumulative effect
Chapter 3 Chapter 3 Drug Action Across the Life Span
Slide 23Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Drug Action Across the Life SpanDrug Action Across the Life Span
• Age and gender affect drug therapy
• Gender-specific medicine
A d l i i th t t di th
Slide 24Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
A developing science that studies the differences in the normal function of men and women and how people of each sex perceive and experience disease
9
Across The Life SpanAge
• <38 weeks• 0-1 month• 1-24 months• 1-5 years• 6-12 years• 13-18 years
Title of Stage• Premature• Newborn, neonate• Infant, baby• Young child• Older child• Adolescent• 13-18 years
• 19-54 years• 55-64 years• 65-74 years• 75-84 years• 85+ years
• Adolescent• Adult• Older adult• Elderly• The aged• The very old
Drug Action Across the Life SpanDrug Action Across the Life Span
In nearly every body system, men and women function differently
Men and women perceive and experience disease differently
Slide 26Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Fundamental questions remain about how humans function and the effect of disease on function
PharmacogeneticsPolymorphisms
Drug Absorption: Age ConsiderationsDrug Absorption: Age Considerations
• Special considerations for pediatric and older adult patients
Differences in muscle mass, blood flow, and inactivity affect medicines given intramuscularly
Slide 27Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
intramuscularly
Topical and transdermal administration differs in the very young and the very old
10
Drug Absorption: Age ConsiderationsDrug Absorption: Age Considerations
• Topical administration in infants is effective because:
Outer layer of skin (stratum corneum) not fully de eloped
Slide 28Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
developed
Skin more fully hydrated; plastic diaper increases skin hydration
Inflammation (diaper rash) increases absorption
Drug Absorption: Age ConsiderationsDrug Absorption: Age Considerations
• Difficult to predict in geriatric patients
Dermal thickness decreases with age and may enhance absorption
Slide 29Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Drying, wrinkling, and decreased hair follicles decrease absorption
Decreased cardiac output and diminishing tissue perfusion also affect absorption
Drug Absorption: Age ConsiderationsDrug Absorption: Age Considerations
• Gastrointestinal absorption influenced by:
Gastric pH
Slide 30Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Gastric emptying time
Enzymatic activity
Blood flow of mucous lining and intestines
11
Drug Absorption: Gender ConsiderationsDrug Absorption: Gender Considerations
• Increased potential for toxicity and slower absorption times in women
Empty solids more slowly
Slide 31Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Have greater gastric acidity
Have lower gastric levels of alcohol dehydrogenase needed to metabolize alcohols
Drug DistributionDrug Distribution• Depends on pH, body water concentrations,
presence and quantity of fat tissue, protein binding, cardiac output, and regional blood flow
I f t h l l f t t t
Slide 32Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Infants have larger volume of water content and require higher dose
• With age, total body water decreases and fat increases
Drug DistributionDrug Distribution
• Highly fat-soluble drugs take longer to act and accumulate in fat tissues, increasing potential for toxicity
P i bi di
Slide 33Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Protein binding Drugs that are relatively insoluble are transported in circulation by binding to plasma proteins
12
Drug DistributionDrug Distribution
Age considerations• Some drugs have lower protein binding in
neonates and require larger loading dose• Albumin levels decrease with age
Slide 34Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Gender considerations• Some differences between men and
women in globulin proteins
Drug MetabolismDrug Metabolism• Drug metabolism
Process by which the body inactivates medicine
Slide 35Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Affected by genes, diet, age & maturity of enzyme systems
Liver weight and hepatic blood flow decrease with age
Routes of Medication Excretion Routes of Medication Excretion
Primary Routes• Renal tubules: into the urine• GI tract: through feces
Minor RoutesMinor Routes• Evaporation: through skin• Exhalation: from the lungs• Secretion: in saliva & breast milk
Slide 36Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc .
13
Drug ExcretionDrug Excretion
• Metabolites of drugs (and sometimes the drug itself) eventually excreted
• Preterm infant has 15% of adult renal
Slide 37Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
capacity; fully functional by 9 to 12 months
Drug Excretion (cont’d)Drug Excretion (cont’d)
• Decreased renal function with age
• No prediction of renal function can be based solely on age because of wide individual
Slide 38Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
y gvariation in changes
Percentages of Body WaterPercentages of Body Water
Slide 39Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
14
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
• Entails measurement of a drug’s concentration in biologic fluids to correlate the dosage administered and the level of medicine in the body with the pharmacologic response
Slide 40Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Timing of drug’s administration and collection of specimen are crucial to accurate interpretation
Use of Monitoring ParametersUse of Monitoring Parameters
• Before administering medicine, assess expected therapeutic actions, side effects, reportable adverse effects, probable drug interactions
Slide 41Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Monitoring parameters related to patient’s age
Monitoring Parameters:Monitoring Parameters:Pediatric PatientsPediatric Patients
• Infants and young children more susceptible to dehydration
• Weight variation affects dosage
Slide 42Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
g g
• Aspirin never to be administered to children
• Allergic reactions occur rapidly in children, most commonly to antibiotics
15
Monitoring Parameters: Older Adult PatientsMonitoring Parameters: Older Adult Patients
• Factors that place older patient at risk:
Reduced renal and hepatic function
Chronic illness
Slide 43Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Polypharmacy—multiple-drug therapy required by chronic illness
A greater likelihood of malnourishment due to polypharmacy
Monitoring Parameters: Older Adult PatientsMonitoring Parameters: Older Adult Patients
• Drug therapy
Take thorough drug history and nutritional assessmentDetermine whether new symptoms have
Slide 44Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
y pbeen induced by existing medicinesGradually taper dosage when discontinuing drugStart at one third to one half normal dosage when initiating therapy; gradually increaseReview regimen periodically
Potentially Inappropriate Medications Potentially Inappropriate Medications for Older Adult Patientsfor Older Adult Patients
Slide 45Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
16
Use of Monitoring Use of Monitoring Parameters: Pregnant WomenParameters: Pregnant Women
• Avoid drugs if at all possible
• When taking woman’s history, be alert to possibility of pregnancy
I i id d l h l
Slide 46Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Instruct patient to avoid drugs, alcohol, tobacco
• Try nonpharmacologic treatments before using medicines
• Avoid herbal medicines
Drugs Known to Be Drugs Known to Be TeratogenicTeratogenic
Slide 47Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Use of Monitoring Parameters: Use of Monitoring Parameters: BreastBreast--Feeding PatientsFeeding Patients
• Some drugs are known to enter breast milk and harm nursing infant
• Discuss all medications with physician
Slide 48Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Take medicine immediately after breast-feeding or just before infant’s longest sleeping period
17
Chapter 7 Chapter 7 Principles of Medication Administration
Slide 49Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Legal and Ethical Legal and Ethical ConsiderationsConsiderations
• Standards of care: developed by the state’s nurse practice act, state and federal law, JCAHO, professional organizations
• Before administering medication, nurse must have:
C t li t ti
Slide 50Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Current license to practiceClear policy statement authorizing the actSigned medication orderUnderstanding of rationale for drug useUnderstanding of drug action, dosing, dilution, route and rate of administration, side effects, adverse effects to report, contraindications
Contents of Patient ChartsContents of Patient Charts
• Summary sheet• Consent forms• Physician’s order form• History and physical exam form
P t
Slide 51Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Progress notes• Critical pathways• Nurses’ notes• Laboratory tests record
18
Contents of Patient ChartsContents of Patient Charts• Graphic record• Flow sheets• Consultation reports• Other diagnostic reports• Medication administration record (MAR) or
Slide 52Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Medication administration record (MAR) or medication profile
• PRN or unscheduled medication record• Case management• Patient education record
Legal and Ethical Legal and Ethical ConsiderationsConsiderations
• Standards of care: developed by the state’s nurse practice act, state and federal law, JCAHO, professional organizations
• Before administering medication, nurse must have:
C t li t ti
Slide 53Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Current license to practiceClear policy statement authorizing the actSigned medication orderUnderstanding of rationale for drug useUnderstanding of drug action, dosing, dilution, route and rate of administration, side effects, adverse effects to report, contraindications
Contents of Patient ChartsContents of Patient Charts• Summary sheet• Consent forms• Physician’s order form• History and physical exam form• Progress notes
Slide 54Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Progress notes• Critical pathways• Nurses’ notes• Laboratory tests record
19
Contents of Patient Charts Contents of Patient Charts (cont’d)(cont’d)
• Graphic record• Flow sheets• Consultation reports• Other diagnostic reports• Medication administration record (MAR) or
Slide 55Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Medication administration record (MAR) or medication profile
• PRN or unscheduled medication record• Case management• Patient education record
The KardexThe Kardex
Slide 56Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Drug Distribution SystemsDrug Distribution Systems
• Floor or ward stock system
• Individual prescription order system
C t t ll d di i t
Slide 57Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Computer-controlled dispensing system
• Unit dose system
• Long-term care unit dose system
20
Narcotic Control SystemsNarcotic Control Systems
Slide 58Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
The Drug OrderThe Drug Order• Stat order
• Standing order
• Renewal order
Slide 59Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• PRN order
• Verbal orders
• Electronic transmission of patient orders
Medication ErrorsMedication Errors• Prescribing errors
• Transcription errors
• Dispensing errors
Slide 60Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Dispensing errors
• Administration errors
• Monitoring errors
21
Nurse ResponsibilitiesNurse Responsibilities• Verification
Nurse makes professional judgment regarding acceptability and safety of the drug order, including type of drug, dose and dose preparation, therapeutic intent, route, potential allergic reactions, or contraindications
Slide 61Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
allergic reactions, or contraindications
• TranscriptionNurse is responsible for verification of orders transcribed by others
The Six RightsThe Six Rights• 1. Right drug
Compare exact spelling and concentration of drug with medication card and drug container; drug label should be read three times
• 2. Right time
Slide 62Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
gStandard abbreviationsStandardized administration timesMaintenance of consistent blood levelsMaximum drug absorptionDiagnostic testingPRN medications
The Six Rights (cont’d)The Six Rights (cont’d)• 3. Right dose
Abnormal hepatic or renal functionNausea and vomitingAccurate dose formsAccurate calculationsCorrect measuring devices
Slide 63Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Correct measuring devices
• 4. Right patientBracelet checkingPediatric and older adult patients
22
The Six RightsThe Six Rights• 5. Right route
IV routeIntramuscular routeIntravenous routeSubcutaneous routeOral route
Slide 64Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Oral route
• 6. Right documentationSafety/ethical considerationsLegal considerationsAlways include date/time, drug name, dose, route, site of administration
Special Documentation Special Documentation CircumstancesCircumstances
• Patient refuses medicationThoroughly record incident and reason for refusal in nurses’ notesNotify physician
Slide 65Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Medication error occursNotify physicianComplete incident report
Chapter 8Chapter 8Percutaneous Administration
Slide 66Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
23
Percutaneous AdministrationPercutaneous Administration• Application of medications to the skin or
mucous membranes for absorption
• Includes:Topical application of ointments, creams, lotions or powders to the skin
Slide 67Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
lotions, or powders to the skinInhalation of aerosolized liquids or gasesInstallation of solutions into the mucous membranes of the mouth, eye, ear, nose, or vagina
• Always follow the six rights of drug administration
PercutaneousPercutaneous AdministrationAdministration
• Premedication assessment and explanation• Patient teaching
Hygiene requirementsProper application techniques and timingCautions particular to drug or drug
Slide 68Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Cautions particular to drug or drug administrationSide effectsWhen to contact physician
PercutaneousPercutaneous AdministrationAdministration
• Documentation
Date, time, drug, dosage, route
Slide 69Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Record ongoing assessment data, including signs of adverse drug effects
24
Creams, Lotions, OintmentsCreams, Lotions, Ointments• Wash hands, put on gloves, position patient
• Clean area
• Wear gloves
Slide 70Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Shake lotion bottle; use tongue blade to remove desired amount of ointment or cream from container
• Use dressings according to orders
Patch TestingPatch Testing• Method to identify sensitivity to contact
materials (soaps, pollen, dyes)
• Allergens on patch placed in contact with back, arms, or thighs
Slide 71Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Patch left in place for 48 hours
• Site aired for 15 minutes, then read
• Emergency equipment must be available in case of anaphylactic response
Patch TestingPatch Testing• Wash hands, put on gloves,position patient
• Clean the area
• Wear gloves
Slide 72Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
g
• Apply dose-measuring applicator paper
• Do not rub in ointment
• Cover area with plastic wrap
25
Transdermal Drug DeliveryTransdermal Drug Delivery• Disk or patch providing controlled release of
medication
• Wash hands,put on gloves,position patient
• Apply topical disk or patch
Slide 73Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Apply topical disk or patch
• Application frequency depends on drug
• Wash hands after application
• Label disk with time, date, nurse initials
Topical PowdersTopical Powders• Particles of medication in a talc base
• Wash hands, put on gloves
• Position the patient
Slide 74Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Position the patient
• Wash and thoroughly dry area
• Apply powder, smooth over area for even coverage
Sublingual and Buccal Sublingual and Buccal TabletsTablets
• Sublingual tablets: placed under the tongue
• Buccal tablets: held in the buccal cavity
• Advantage: rapid absorption and onset of
Slide 75Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Advantage: rapid absorption and onset of action
• Action is usually systemic, rather than localized to the mouth
26
Eye Drops, Ointments, and Eye Drops, Ointments, and DisksDisks
• OD (right eye), OS (left eye), OU (both eyes)
• Wash hands, put on gloves,position patient
• Inspect affected eye
Slide 76Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Inspect affected eye
• Expose lower conjunctival sac
• Approach eye from below
• Never touch eye with dropper, tube
Ear DropsEar Drops• Ensure ear is clear of wax
• Warm medication to room temperature
• Younger than age 3: pull earlobe downward and back
Slide 77Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
and back
• Older than age 3 and adults: pull earlobe upward and back
• Patient should remain on side for a few minutes
Nose Drops, Nasal SprayNose Drops, Nasal Spray• Patient should blow nose gently• Nose drops
Position patient lying down with head hanging back
• Nose spray
Slide 78Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Patient is uprightBlock one nostrilShake bottle and insert tip into nostrilSpray while patient inhales
27
Nebulizers and InhalersNebulizers and Inhalers• Nebulizers
Prepare medication and fill nebulizerPatient exhalesPut nebulizer in mouth; do not seal completelyPatient inhales
Slide 79Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Metered-dose inhalersFollow instructions on inhaler
• Dry powder inhalersFollow instructions on inhaler
Vaginal MedicationsVaginal Medications• Wash hands, put on gloves• Fill applicator• Place patient in lithotomy position, elevate
hips with pillow• Spread labia and insert applicator or
Slide 80Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
p ppsuppository
Chapter 9Chapter 9Enteral Administration
Slide 81Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
28
Administration of Oral Administration of Oral MedicationsMedications
• Enteral is direct administration to the GI tract• Most drugs are available in oral dose forms:
Capsules—small, cylindrical gelatin containers used to administer unpleasant tasting medications; timed-release capsules (provides a gradual and continuous release of the drug);
Slide 82Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
gradual and continuous release of the drug); lozenges or troches—flat disks in a flavored baseTablets (powdered drugs that have been compressed)Elixirs—drugs dissolved in water and alcoholEmulsions of water-in-oil or oil-in-waterLiquid suspensions and syrups
Administration of Oral Administration of Oral MedicationsMedications
• Common methods used to administer oral medications
Unit dose packaging providing a single dose Soufflé cupsMedicine cups
Slide 83Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Medicine cupsMedicine droppers Teaspoons Oral syringes: plastic syringes calibrated and used to measure liquid medications Nipples with additional holes, used for infants
Administration of SolidAdministration of Solid--Form Form Oral MedicationsOral Medications
• Two techniques for administering medications: the medication card and unit dose distribution
• Perform premedication assessment in all cases
• All techniques follow FIVE RIGHTS procedure:
Slide 84Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
All techniques follow FIVE RIGHTS procedure:RIGHT patientRIGHT drugRIGHT route of administrationRIGHT doseRIGHT time of administration
• ALWAYS check or recheck the FIVE RIGHTS
29
Administration of SolidAdministration of Solid--Form Form Oral MedicationsOral Medications
• General principles apply to all distribution systemsGive the most important medications firstDo not touch the medication with your handsEncourage liquid intake to ensure swallowingRemain with patient while medication is taken; DO
Slide 85Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Remain with patient while medication is taken; DO NOT leave the medication at bedside unless an order to do so existsDiscard the medication container
• Provide complete documentation of administration and responses to therapy
Administration of SolidAdministration of Solid--Form Form Oral MedicationsOral Medications
• Documentation of medication administration and responses to drug therapy is called the “Sixth Right”
• General principles apply to all medication administration
Chart date, time, drug name, dosage, and route of d i i t ti
Slide 86Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
administrationRegularly record patient assessments to evaluate therapeutic effectivenessChart and report any sign of adverse drug effects
• Perform and validate essential education about drug therapy and other aspects of intervention for the individual
Administration of LiquidAdministration of Liquid--Form Form Oral MedicationsOral Medications
• General procedures are the same as with solid-form oral medications
• Perform premedication assessment in all cases
Slide 87Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• All techniques follow the FIVE RIGHTS procedure
30
Administration of LiquidAdministration of Liquid--Form Form Oral Medications (cont’d)Oral Medications (cont’d)
• General principles for infants, children, and adults
Give adults and children the most important medications firstNEVER dilute medications without specific orders. DO NOT leave a medication at the
Slide 88Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
bedside without an order to do soCheck an infant’s ID and be certain the infant is alert
• Provide complete documentation of administration and responses to therapy
Administration of LiquidAdministration of Liquid--Form Form Oral MedicationsOral Medications
• Measuring techniques vary according to receptacle used
• With a measuring cup:Cover label to prevent smearing; place fingernail at exact level on measuring cup;
Slide 89Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
fingernail at exact level on measuring cup; read the volume at the level of meniscus—see Figure 9-13. Recheck FIVE RIGHTS.
• With an oral syringe:Select syringe of appropriate size. Draw up prescribed volume of medication from bottle or medicine cup
Administration of Medications Administration of Medications by Nasogastric Tubeby Nasogastric Tube
• Drugs are administered via NG tube for specific patients, using a liquid form whenever possible. Remember:
Always flush the tube before and after administrationPerform premedication assessment
Slide 90Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
pAssemble equipment before administration
31
Administration of Medications Administration of Medications by Nasogastric Tube (cont’d)by Nasogastric Tube (cont’d)
• Prepare doses as for administration of solid-form or liquid-liquid form oral medications
• Three methods for checking NG tube location• Follow procedure for administering
di i
Slide 91Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
medication • DO NOT attach suction for 30+ minutes• Provide complete documentation of
administration and responses to therapy
Administration of Enteral Feedings via Administration of Enteral Feedings via Gastrostomy of Jejunostomy TubeGastrostomy of Jejunostomy Tube
• Enteral formulas are in several mixtures to meet individual needs
• Assemble equipment beforehand• Prescribed enteral formula should be
checked
Slide 92Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Administration of Enteral Feedings Via Administration of Enteral Feedings Via Gastrostomy or Jejunostomy Tube (cont’d)Gastrostomy or Jejunostomy Tube (cont’d)
• Formula should be fully labeled • Discard unused formula every 24 hours• Follow the guidelines specific for patients
receiving general nutrition via intermittent or
Slide 93Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
continuous feedings• Follow FIVE RIGHTS
RIGHT patient, RIGHT drug (formula), RIGHT route of administration, RIGHT dose (amount, dilution, strength), RIGHT time
32
Administration of Enteral Feedings via Administration of Enteral Feedings via Gastrostomy or Jejunostomy Tube (cont’d)Gastrostomy or Jejunostomy Tube (cont’d)
• Verify tube placement and initiate feeding• Flush, then clamp tube• Proceed with tube feeding technique
Intermittent: use Toomey syringe
Slide 94Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
y y gContinuous: use disposable feeding container and enough formula for a 4-hour period
• Provide complete documentation of administration and responses to therapy
Administration of Rectal Administration of Rectal SuppositoriesSuppositories
• Suppositories are solid medication designed to dissolve inside a body orifice
• Equipment is simple:Finger cot or disposable gloveWater-soluble lubricantP ib d it
Slide 95Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Prescribed suppository• Perform standard premedication assessment
Administration of Rectal Administration of Rectal Suppositories (cont’d)Suppositories (cont’d)
• Technique begins with FIVE RIGHTSExplain procedure and check pertinent parametersPatient bends uppermost legA l l b i t t ti f it Pl
Slide 96Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Apply lubricant to tip of suppository. Place suppository about 1 inch beyond orifice, past internal sphincter
• Provide complete documentation of administration and responses to therapy
33
Administration of a Disposable Administration of a Disposable EnemaEnema
• The dose form will be a prepackaged, disposable-type enema solution
• Equipment is simple• Perform standard premedication assessment
Slide 97Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Administration of a Disposable Administration of a Disposable Enema (cont’d)Enema (cont’d)
• Technique begins with FIVE RIGHTSExplain procedure and check pertinent parameters• Time of last defecation
P ti t b d t l
Slide 98Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Patient bends uppermost legApply lubricant to rectal tube Insert lubricated tube and insert solution
• Provide complete documentation of administration and responses to therapy
Parenteral AdministrationParenteral Administration• Parenteral means drug administration by any
route other than the gastrointestinal tract
• Parenteral routeIntradermal
Slide 99Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
SubcutaneousIntramuscular (IM)Intravenous (IV)
34
Chapter 10Chapter 10Parenteral Administration: Safe Preparation of Parenteral Medications
Slide 100Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Equipment Used in Parenteral Equipment Used in Parenteral AdministrationAdministration
• The syringe has three parts: barrel, plunger, and tip
• Syringes are calibrated in minims, milliliters, or cubic centimeters
• Tuberculin syringes are used to measure ll l f di ti t l
Slide 101Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
small volumes of medication accurately
Equipment Used in Parenteral Equipment Used in Parenteral Administration (cont’d)Administration (cont’d)
• The insulin syringe has a special scale for measuring insulin
• In the United States, insulin is manufactured in U-100 concentration
Slide 102Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
in U-100 concentrationThe U-100 syringe holds 100 units of insulin per milliliterLow-dose insulin syringes are used for patients receiving 50 units or less of U-100 insulin
35
Equipment Used in Parenteral Equipment Used in Parenteral Administration (cont’d)Administration (cont’d)
• Prefilled syringes are disposable and have a premeasured amount of medication
Advantages: time saved in preparation, less h f t i ti
Slide 103Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
chance of contamination
Disadvantages: additional expense, different holders for different cartridges, volume of second medication limited
Equipment Used in Parenteral Equipment Used in Parenteral Administration (cont’d)Administration (cont’d)
• The needle has three parts:HubShaftBeveled tip
Slide 104Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• The needle gauge is the diameter of the hole through the needle
• Needle selection depends on age of patient, and site (subcutaneous, IM, or IV)—see Table 10-1
Equipment Used in Parenteral Equipment Used in Parenteral Administration (cont’d)Administration (cont’d)
• Major safety development: needleless systems
Provide an alternative to needles for routine
Slide 105Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Provide an alternative to needles for routine procedures, reducing the risk of needlesticks with contaminated sharps
36
Equipment Used in Parenteral Equipment Used in Parenteral Administration (cont’d)Administration (cont’d)
• Other safety devices have been developed
BD Safety-Lok SyringeBD SafetyGlide Shielding Hypodermic Needle
Slide 106Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
BD SafetyGlide Shielding Hypodermic NeedleBD SafetyGlide Syringe Tiny Needle TechnologyBD Integra Syringe
Parenteral Dose FormsParenteral Dose Forms• Ampules
Glass containers usually containing a single dose
• Vials
Slide 107Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Glass containers that contain one or more doses
• Mix-O-VialsGlass containers with one dose, two compartments
Preparation of Parenteral Preparation of Parenteral MedicationMedication
• Equipment needed for preparation of parenteral medications
Drug in sterile, sealed container
Slide 108Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Syringe of the correct volumeNeedles of the correct gauge and lengthNeedleless access deviceAntiseptic swabMAR or medication profile
37
Preparation of Preparation of ParenteralParenteralMedicationMedication
• Techniques for preparing all parenteral medications
Use the five RIGHTS: Right Patient, Right D Ri ht R t f Ad i i t ti Ri ht
Slide 109Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Drug, Right Route of Administration, Right Dose (Amount and Concentration), Right Time of Administration
Check the drug dose form ordered against the source you are holding
Preparing a Medication from Preparing a Medication from an Ampulean Ampule
• Move solution to the bottom of the ampule
• Cover the ampule neck with a sterile gauze pledget or antiseptic swab while breaking off top
Slide 110Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
top
• Using an aspiration needle, withdraw medication from ampule
Preparing a Medication from Preparing a Medication from an an AmpuleAmpule
• Remove the needle from the ampule and point the needle vertically
• Pull back the plunger. Replace the aspiration needle with a new sterile needle
Slide 111Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
needle with a new sterile needle
• Push plunger until medication is at tip of needle
38
Preparing a Medication from a Preparing a Medication from a VialVial
• Cleanse the top of the vial of diluent
• Pull plunger of syringe to fill with an amount of air equal to the volume of the solution to be withdrawn
Slide 112Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
withdrawn
• Insert the needle or needleless access device through the diaphragm, inject air
• Withdraw the measured volume of diluent required to reconstitute the powdered drug
Preparing a Medication from a VialPreparing a Medication from a Vial
• Tap the vial of powdered drug to break up caked powder; cleanse the rubber diaphragm with swab
• Insert the needle or needleless access device i th di h d i j t th dil t i th
Slide 113Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
in the diaphragm and inject the diluent in the powder
• Mix thoroughly to dissolve powder
• Change needle to correct gauge and length to administer the medication to the patient
Preparing a Medication from a Preparing a Medication from a MixMix--OO--VialVial
• Tap the container a few times to break up the caked powder
• Remove the plastic lid protector
Slide 114Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Push firmly on the diaphragm-plunger
• Mix thoroughly
• Cleanse the rubber diaphragm and remove drug using syringe to administer to patient
39
Special PreparationsSpecial Preparations
• Occasionally two medications may be drawn into the same syringe for a single injection
M di ti d t b d f i
Slide 115Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
• Medications need to be prepared for use in the sterile field during a surgical procedure